We are live on
!
Find out more
GE
General Electric Portfolio holdings
AUM
$369M
1-Year Est. Return
19.65%
This Fund
S&P 500
This Quarter
Est. Return
-3.92%
1 Year Est. Return
-19.65%
3 Year Est. Return
-47.53%
5 Year Est. Return
-4.4%
10 Year Est. Return
+30.79%
AUM
$180M
AUM Growth
-$14M
(-7.2%)
Cap. Flow
-$2.54M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$201K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veracyte
VCYT
|
+$2.01M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$726K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 71.72% |
| 2 | Industrials | 25.36% |
| 3 | Technology | 2.8% |
| 4 | Materials | 0.11% |
Similar funds
GIM
AWA
JF
SPM
GFPC
WAOI
CRI
OG
General Electric's Q4 2016 Portfolio in Review
As of Q4 2016, General Electric held 7 positions worth $180M, down 7.2% from $194M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
General Electric's Q4 2016 filing shows 1 new and 2 closed positions. Its largest new stake was LyondellBasell Industries: 2,399 shares worth $205K. The largest sale was Veracyte, an estimated $2.01M.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 65% a quarter earlier, followed by Industrials and Technology.
- General Electric's largest Q4 2016 buy was LyondellBasell Industries: 2,399 shares worth $205K.
- General Electric fully exited Veracyte in Q4 2016, selling an estimated $2.01M.
- General Electric's ten largest holdings make up 100% of its $180M portfolio in Q4 2016.
- General Electric opened 1 new position and closed 2 in Q4 2016.
- General Electric's portfolio value fell 7.2% quarter-over-quarter to $180M.
Based on General Electric's 13F filing for Q4 2016, filed 13 Feb 2017.